EP2 receptor agonists for treating glaucoma

Details for Australian Patent Application No. 2006285177 (hide)

Owner Allergan Inc.

Inventors Woodward, David F.; Chen, June

Agent Davies Collison Cave

Pub. Number AU-A-2006285177

PCT Pub. Number WO2007/027468

Priority 11/472,145 21.06.06 US; 60/712,586 29.08.05 US

Filing date 21 August 2006

Wipo publication date 8 March 2007

International Classifications

C07D 213/71 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/4406 (2006.01) - only substituted in position 3, e.g. zimeldine

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

A61P 27/06 (2006.01) Drugs for disorders of the senses

Event Publications

25 October 2007 PCT application entered the National Phase

  PCT publication WO2007/027468 Priority application(s): WO2007/027468

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006285181-Fiber optic universal bracket apparatus

2006285168-Hearing protective device that includes cellular earmuffs